Evidence map›Paper›PMID 42579205›Full record

ArticleWorld journal of microbiology & biotechnology2026

Investigation of the anti-microbial and anti-inflammatory properties of Weizmannia coagulans MBBCM9™ and formulation of a probiotic oral health product.

Tanvi Sawant, Pankti Ganatra, Pooja Sawant, Ameya Parkar, Mruduka Patel, Nikunj Patel, Gaurav Kaushik, Prajakta Dandekar, Ratnesh Jain

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tanvi SawantDepartment of Biological Sciences and Biotechnology, Institute of Chemical Technology, Nathalal Parekh Marg, Matunga, Mumbai, 400019, India.
Pankti GanatraDepartment of Biological Sciences and Biotechnology, Institute of Chemical Technology, Nathalal Parekh Marg, Matunga, Mumbai, 400019, India.
Pooja SawantDepartment of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Nathalal Parekh Marg, Matunga, Mumbai, 400019, India.
Ameya ParkarDepartment of Biological Sciences and Biotechnology, Institute of Chemical Technology, Nathalal Parekh Marg, Matunga, Mumbai, 400019, India.
Mruduka PatelMeteoric Biopharmaceuticals PVT LTD, Ahmedabad, 380015, Gujarat, India.
Nikunj PatelMeteoric Biopharmaceuticals PVT LTD, Ahmedabad, 380015, Gujarat, India.
Gaurav KaushikMeteoric Biopharmaceuticals PVT LTD, Ahmedabad, 380015, Gujarat, India.
Prajakta DandekarDepartment of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Nathalal Parekh Marg, Matunga, Mumbai, 400019, India. pd.jain@ictmumbai.edu.in.
Ratnesh JainDepartment of Biological Sciences and Biotechnology, Institute of Chemical Technology, Nathalal Parekh Marg, Matunga, Mumbai, 400019, India. rd.jain@ictmumbai.edu.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Probiotics with anti-microbial and anti-inflammatory activity can help manage caries, plaque, and gingivitis. Routine oral-care products can serve as effective delivery vehicles for probiotic administration, and spore-forming probiotics are well suited for this application because they can survive, germinate, and provide sustained benefits. A spore-forming probiotic Weizmannia coagulans MBBCM9™ was selected for the study that demonstrated partial germination (28.70 ± 0.77%) in artificial saliva under in-vitro conditions within 2 h, as indicated by a reduction in OD

Indexed as

Anti-Infective AgentsAnti-Inflammatory AgentsProbioticsBiofilmsFibroblastsGingivaHumansMicrobial Sensitivity TestsPlant ExtractsSaliva, ArtificialStreptococcus mutansAnti-Infective AgentsAnti-Inflammatory AgentsPlant ExtractsSaliva, Artificialanti-biofilmanti-inflammatoryanti-microbialformulationphysicochemical testsProbiotic dentifriceprobiotic stabilityWeizmannia coagulans MBBCM9™

Identifiers

PMID42579205

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.